BJDX News and Press, Bluejay Diagnostics Inc. From 08/09/25

Bluejay Diagnostics Inc. (BJDX) is expected to report for Q2 2025

ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced financial results for the quarter ended June 30...

2025-06-06 10:00:23 ET DENVER, Colo., Jun 06, 2025 ( 247marketnews.com )- Keep your eyes on these high-momentum names as catalysts continue to build across biotech, AI, M&A, and squeeze setups: Webuy Global (NASDAQ:WBUY) Webuy is showing serious squeeze potential with grow...

ACTON, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient testing solutions for critical care, today provided a 2025 mid-year business and corporate...

2025-04-15 15:40:08 ET Bluejay (NASDAQ: BJDX) is a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings. The company recently announced its entry into an agreement with institutional investors to exercise ...

ACTON, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today announced acceptance of an abstract related to the Symphony IL-6 Test, the company’s lead product candidate, for presentation at the Society of Academic Emergency Medicine (SAEM) Annual Meeting...

2025-04-07 17:29:34 ET More on Bluejay Diagnostics Financial information for Bluejay Diagnostics Read the full article on Seeking Alpha For further details see: Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal

ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today ...

HG Holdings Inc (STLY) is expected to report for quarter end 2024-12-31 Savara Inc. (SVRA) is expected to report $-0.11 for Q4 2024 Reborn Coffee Inc. (REBN) is expected to report for quarter end 2024-12-31 VSee Health Inc. (VSEE) is expected to report for Q4 2024 IceCure Medical ...